Literature DB >> 9196523

Gamma/delta T lymphocytes in Mycobacterium tuberculosis infection.

Z Balikó1, L Szereday, J Szekeres-Bartho.   

Abstract

BACKGROUND: Data on the percentage of gamma/delta T lymphocytes in the peripheral blood of patients infected with Mycobacterium tuberculosis are few and contradictory. The percentage of gamma/delta T lymphocytes in the peripheral blood of tuberculin positive and tuberculin negative patients with Mycobacterium tuberculosis infection and healthy controls was compared.
METHODS: Thirty six patients infected with Mycobacterium tuberculosis and 11 healthy controls were studied. Lymphocytes were separated, cytocentrifuged onto glass microscope slides, and reacted with anti-gamma/delta monoclonal antibody. The percentage of gamma/delta positive cells was determined by microscopic counting of 300 lymphocytes.
RESULTS: No difference was found in the percentage of gamma/delta T lymphocytes between patients and controls. However, when the patients were divided into two groups according to reactivity or non-reactivity in the Mantoux skin reaction a higher percentage of gamma/delta T lymphocytes was found in the peripheral blood of patients with tuberculin anergy than in tuberculin positive patients or controls.
CONCLUSIONS: Higher gamma/delta T cell counts are found in tuberculin negative patients with tuberculosis than in tuberculin positive patients or tuberculin positive controls. The high gamma/delta T cell counts in tuberculin anergic patients may reflect a shift in the immune response in a Th2 direction characterised by increased antibody production and decreased cell mediated responses.

Entities:  

Mesh:

Year:  1997        PMID: 9196523      PMCID: PMC1758541          DOI: 10.1136/thx.52.4.375

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  7 in total

1.  Increased proportions of peripheral blood gamma delta T cells in patients with pulmonary tuberculosis.

Authors:  M Ito; N Kojiro; T Ikeda; T Ito; J Funada; T Kokubu
Journal:  Chest       Date:  1992-07       Impact factor: 9.410

Review 2.  Issues concerning the nature of antigen recognition by alpha beta and gamma delta T-cell receptors.

Authors:  M M Davis; Y Chien
Journal:  Immunol Today       Date:  1995-07

3.  Increase of gamma/delta T cells in hospital workers who are in close contact with tuberculosis patients.

Authors:  C Ueta; I Tsuyuguchi; H Kawasumi; T Takashima; H Toba; S Kishimoto
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

4.  Global epidemiology of tuberculosis. Morbidity and mortality of a worldwide epidemic.

Authors:  M C Raviglione; D E Snider; A Kochi
Journal:  JAMA       Date:  1995-01-18       Impact factor: 56.272

5.  Gamma delta T lymphocytes in human tuberculosis.

Authors:  P F Barnes; C L Grisso; J S Abrams; H Band; T H Rea; R L Modlin
Journal:  J Infect Dis       Date:  1992-03       Impact factor: 5.226

6.  Characterization of gamma/delta T-lymphocytes in the peripheral blood of patients with active tuberculosis. A comparison with normal subjects and patients with sarcoidosis.

Authors:  A Tazi; F Bouchonnet; D Valeyre; J Cadranel; J P Battesti; A J Hance
Journal:  Am Rev Respir Dis       Date:  1992-11

7.  Modulation of immunogenicity and antigenicity of proteins by maleylation to target scavenger receptors on macrophages.

Authors:  R Abraham; N Singh; A Mukhopadhyay; S K Basu; V Bal; S Rath
Journal:  J Immunol       Date:  1995-01-01       Impact factor: 5.422

  7 in total
  2 in total

1.  Gamma/delta T cell subsets in patients with active Mycobacterium tuberculosis infection and tuberculin anergy.

Authors:  L Szereday; Z Baliko; J Szekeres-Bartho
Journal:  Clin Exp Immunol       Date:  2003-02       Impact factor: 4.330

2.  Phenotypic and functional heterogeneity of peripheral γδ T cells in pulmonary TB and HIV patients in Addis Ababa, Ethiopia.

Authors:  Mikias Negash; Aster Tsegaye; Liya Wassie; Rawleigh Howe
Journal:  BMC Infect Dis       Date:  2018-09-15       Impact factor: 3.090

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.